- Home
- CDTX vs ABSI Comparison
CDTX vs ABSI Comparison
Compare CDTX & ABSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDTX
- ABSI
- Stock Information
- Founded
- CDTX 2012
- ABSI 2011
- Country
- CDTX United States
- ABSI United States
- Employees
- CDTX N/A
- ABSI N/A
- Industry
- CDTX Biotechnology: Biological Products (No Diagnostic Substances)
- ABSI Biotechnology: Pharmaceutical Preparations
- Sector
- CDTX Health Care
- ABSI Health Care
- Exchange
- CDTX Nasdaq
- ABSI Nasdaq
- Market Cap
- CDTX 333.3M
- ABSI 338.0M
- IPO Year
- CDTX 2015
- ABSI 2021
- Fundamental
- Price
- CDTX $47.64
- ABSI $2.53
- Analyst Decision
- CDTX Strong Buy
- ABSI Strong Buy
- Analyst Count
- CDTX 11
- ABSI 5
- Target Price
- CDTX $52.11
- ABSI $8.40
- AVG Volume (30 Days)
- CDTX 1.2M
- ABSI 3.6M
- Earning Date
- CDTX 08-12-2025
- ABSI 08-13-2025
- Dividend Yield
- CDTX N/A
- ABSI N/A
- EPS Growth
- CDTX N/A
- ABSI N/A
- EPS
- CDTX N/A
- ABSI N/A
- Revenue
- CDTX $302,000.00
- ABSI $4,815,000.00
- Revenue This Year
- CDTX N/A
- ABSI $81.76
- Revenue Next Year
- CDTX N/A
- ABSI $287.79
- P/E Ratio
- CDTX N/A
- ABSI N/A
- Revenue Growth
- CDTX N/A
- ABSI N/A
- 52 Week Low
- CDTX $10.14
- ABSI $2.01
- 52 Week High
- CDTX $56.83
- ABSI $6.33
- Technical
- Relative Strength Index (RSI)
- CDTX 77.41
- ABSI 35.28
- Support Level
- CDTX $45.42
- ABSI $2.64
- Resistance Level
- CDTX $50.48
- ABSI $2.86
- Average True Range (ATR)
- CDTX 3.83
- ABSI 0.16
- MACD
- CDTX 2.31
- ABSI -0.03
- Stochastic Oscillator
- CDTX 74.94
- ABSI 5.59
About CDTX Cidara Therapeutics Inc.
Cidara Therapeutics Inc is developing immunotherapeutics designed to help improve the standard of care for patients facing serious diseases. Its clinical-stage asset is CD388, a DFC intended for influenza prophylaxis. The Company's portfolio comprises new approaches aimed at transforming existing treatment and prevention paradigms, including DFCs from its proprietary Cloudbreak platform targeting oncologic, viral and autoimmune diseases.
About ABSI Absci Corporation
Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process.